Works matching AU Singer, Daniel E.


Results: 142
    1
    2

    Prevalence of Diagnosed Atrial Fibrillation in Adults.

    Published in:
    JAMA: Journal of the American Medical Association, 2001, v. 285, n. 18, p. 2370, doi. 10.1001/jama.285.18.2370
    By:
    • Go, Alan S.;
    • Hylek, Elaine M.;
    • Phillips, Kathleen A.;
    • Chang, YuChiao;
    • Henault, Lori E.;
    • Selby, Joe V.;
    • Singer, Daniel E.
    Publication type:
    Article
    3

    Patients With Atrial Fibrillation at Low Risk of Stroke.

    Published in:
    JAMA: Journal of the American Medical Association, 1998, v. 280, n. 10, p. 882, doi. 10.1001/jama.280.10.882
    By:
    • Cheung, Raymond;
    • Singer, Daniel E.;
    • McBride, Ruth;
    • Hart, Robert G.;
    • Halperin, Jonathan L.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial.

    Published in:
    European Heart Journal, 2015, v. 36, n. 5, p. 288
    By:
    • Steinberg, Benjamin A.;
    • Hellkamp, Anne S.;
    • Lokhnygina, Yuliya;
    • Patel, Manesh R.;
    • Breithardt, Günter;
    • Hankey, Graeme J.;
    • Becker, Richard C.;
    • Singer, Daniel E.;
    • Halperin, Jonathan L.;
    • Hacke, Werner;
    • Nessel, Christopher C.;
    • Berkowitz, Scott D.;
    • Mahaffey, Kenneth W.;
    • Fox, Keith A.A.;
    • Califf, Robert M.;
    • Piccini, Jonathan P.
    Publication type:
    Article
    14

    Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial.

    Published in:
    European Heart Journal, 2014, v. 35, n. 47, p. 3377, doi. 10.1093/eurheartj/ehu305
    By:
    • Breithardt, Günter;
    • Baumgartner, Helmut;
    • Berkowitz, Scott D.;
    • Hellkamp, Anne S.;
    • Piccini, Jonathan P.;
    • Stevens, Susanna R.;
    • Lokhnygina, Yuliya;
    • Patel, Manesh R.;
    • Halperin, Jonathan L.;
    • Singer, Daniel E.;
    • Hankey, Graeme J.;
    • Hacke, Werner;
    • Becker, Richard C.;
    • Nessel, Christopher C.;
    • Mahaffey, Kenneth W.;
    • Fox, Keith A. A.;
    • Califf, Robert M.
    Publication type:
    Article
    15

    Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.

    Published in:
    European Heart Journal, 2014, v. 35, n. 28, p. 1873
    By:
    • Piccini, Jonathan P.;
    • Garg, Jyotsna;
    • Patel, Manesh R.;
    • Lokhnygina, Yuliya;
    • Goodman, Shaun G.;
    • Becker, Richard C.;
    • Berkowitz, Scott D.;
    • Breithardt, Günter;
    • Hacke, Werner;
    • Halperin, Jonathan L.;
    • Hankey, Graeme J.;
    • Nessel, Christopher C.;
    • Mahaffey, Kenneth W.;
    • Singer, Daniel E.;
    • Califf, Robert M.;
    • Fox, Keith A. A.
    Publication type:
    Article
    16
    17
    18

    Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial.

    Published in:
    European Heart Journal, 2014, v. 35, n. 4, p. 233
    By:
    • Mahaffey, Kenneth W.;
    • Stevens, Susanna R.;
    • White, Harvey D.;
    • Nessel, Christopher C.;
    • Goodman, Shaun G.;
    • Piccini, Jonathan P.;
    • Patel, Manesh R.;
    • Becker, Richard C.;
    • Halperin, Jonathan L.;
    • Hacke, Werner;
    • Singer, Daniel E.;
    • Hankey, Graeme J.;
    • Califf, Robert M.;
    • Fox, Keith A.A.;
    • Breithardt, Günter
    Publication type:
    Article
    19
    20

    Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.

    Published in:
    European Heart Journal, 2011, v. 32, n. 19, p. 2387, doi. 10.1093/eurheartj/ehr342
    By:
    • Fox, Keith A.A.;
    • Piccini, Jonathan P.;
    • Wojdyla, Daniel;
    • Becker, Richard C.;
    • Halperin, Jonathan L.;
    • Nessel, Christopher C.;
    • Paolini, John F.;
    • Hankey, Graeme J.;
    • Mahaffey, Kenneth W.;
    • Patel, Manesh R.;
    • Singer, Daniel E.;
    • Califf, Robert M.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26

    Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.

    Published in:
    Journal of the American Heart Association, 2018, v. 7, n. 18, p. 1, doi. 10.1161/JAHA.118.008928
    By:
    • Washam, Jeffrey B.;
    • Holmes, DaJuanicia N.;
    • Thomas, Laine E.;
    • Pokorney, Sean D.;
    • Hylek, Elaine M.;
    • Fonarow, Gregg C.;
    • Mahaffey, Kenneth W.;
    • Gersh, Bernard J.;
    • Kowey, Peter R.;
    • Ansell, Jack E.;
    • Go, Alan S.;
    • Reiffel, James A.;
    • Freeman, James V.;
    • Singer, Daniel E.;
    • Naccarelli, Gerald;
    • Blanco, Rosalia;
    • Peterson, Eric D.;
    • Piccini, Jonathan P.
    Publication type:
    Article
    27
    28
    29
    30

    Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).

    Published in:
    2018
    By:
    • Steinberg, Benjamin A.;
    • Shrader, Peter;
    • Pieper, Karen;
    • Thomas, Laine;
    • Allen, Larry A.;
    • Ansell, Jack;
    • Chan, Paul S.;
    • Ezekowitz, Michael D.;
    • Fonarow, Gregg C.;
    • Freeman, James V.;
    • Gersh, Bernard J.;
    • Kowey, Peter R.;
    • Mahaffey, Kenneth W.;
    • Naccarelli, Gerald V.;
    • Reiffel, James A.;
    • Singer, Daniel E.;
    • Peterson, Eric D.;
    • Piccini, Jonathan P.;
    • the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF) II Investigators;
    • Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF) II Investigators
    Publication type:
    journal article
    31

    Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).

    Published in:
    Journal of the American Heart Association, 2017, v. 6, n. 12, p. 1, doi. 10.1161/JAHA.117.006475
    By:
    • Thomas, Kevin L.;
    • Jackson II, Larry R.;
    • Shrader, Peter;
    • Ansell, Jack;
    • Fonarow, Gregg C.;
    • Gersh, Bernard;
    • Kowey, Peter R.;
    • Mahaffey, Kenneth W.;
    • Singer, Daniel E.;
    • Thomas, Laine;
    • Piccini, Jonathan P.;
    • Peterson, Eric D.
    Publication type:
    Article
    32
    33
    34

    Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial.

    Published in:
    Journal of the American Heart Association, 2017, v. 6, n. 6, p. 1, doi. 10.1161/JAHA.116.004663
    By:
    • Leef, George C.;
    • Hellkamp, Anne S.;
    • Patel, Manesh R.;
    • Becker, Richard C.;
    • Berkowitz, Scott D.;
    • Breithardt, Günter;
    • Halperin, Jonathan L.;
    • Hankey, Graeme J.;
    • Hacke, Werner;
    • Nessel, Christopher C.;
    • Singer, Daniel E.;
    • Fox, Keith A. A.;
    • Mahaffey, Kenneth W.;
    • Piccini, Jonathan P.
    Publication type:
    Article
    35
    36
    37

    Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

    Published in:
    2016
    By:
    • Pokorney, Sean D.;
    • Piccini, Jonathan P.;
    • Stevens, Susanna R.;
    • Patel, Manesh R.;
    • Pieper, Karen S.;
    • Halperin, Jonathan L.;
    • Breithardt, Günter;
    • Singer, Daniel E.;
    • Hankey, Graeme J.;
    • Hacke, Werner;
    • Becker, Richard C.;
    • Berkowitz, Scott D.;
    • Nessel, Christopher C.;
    • Mahaffey, Kenneth W.;
    • Fox, Keith A. A.;
    • Califf, Robert M.;
    • ROCKET AF Steering Committee & Investigators
    Publication type:
    journal article
    38
    39
    40

    Relationship Between Time in Therapeutic Range and Comparative Treatment Effect of Rivaroxaban and Warfarin: Results From the ROCKET AF Trial.

    Published in:
    Journal of the American Heart Association, 2014, v. 3, n. 1, p. 1, doi. 10.1161/JAHA.113.000521
    By:
    • Piccini, Jonathan P.;
    • Hellkamp, Anne S.;
    • Lokhnygina, Yuliya;
    • Patel, Manesh R.;
    • Harrell, Jr, Frank E.;
    • Singer, Daniel E.;
    • Becker, Richard C.;
    • Breithardt, Günter;
    • Halperin, Jonathan L.;
    • Hankey, Graeme J.;
    • Berkowitz, Scott D.;
    • Nessel, Christopher C.;
    • Mahaffey, Kenneth W.;
    • Fox, Keith A. A.;
    • Califf, Robert M.
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49

    A Controlled Trial of Population Management.

    Published in:
    Diabetes Care, 2004, v. 27, n. 10, p. 2299, doi. 10.2337/diacare.27.10.2299
    By:
    • Grant, Richard W.;
    • Cagliero, Enrico;
    • Sullivan, Christine M.;
    • Dubey, Anil K.;
    • Estey, Greg A.;
    • Weil, Eric M.;
    • Gesmundo, Joseph;
    • Nathan, David M.;
    • Singer, Daniel E.;
    • Chueh, Henry C.;
    • Meigs, James B.
    Publication type:
    Article
    50